XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.3
RESTATEMENT OF CONSOLIDATED FINANCIAL STATEMENTS (Tables)
3 Months Ended
Sep. 30, 2018
Accounting Changes and Error Corrections [Abstract]  
RESTATEMENT OF CONSOLIDATED FINANCIAL STATEMENTS
A summary of the impact of these matters on income (loss) before taxes is presented below:
($ in thousands)
Increase / (Decrease) Restatement Impact
 
Three months ended September 30, 2017
Audit Committee Investigation-related Adjustments:
 
Revenue
$
(411
)
Costs of sales
$
165

Gross profit
$
(576
)
Operating loss
$
(576
)
Loss before income taxes
$
(576
)
 
 
Significant Account and Transaction Review and Other:
 
Revenue
$
53

Costs of sales
$
497

Gross profit
$
(444
)
Operating loss
$
(622
)
Loss before income taxes
$
(886
)
A summary of the impact of these matters on the condensed consolidated balance sheet is presented below, excluding any tax effect from the restatement adjustments in the aggregate:
($ in thousands)
Increase / (Decrease) Restatement Impact
 
As of September 30, 2017
Audit Committee Investigation-related Adjustments:
 
Accounts receivable
$
(315
)
Finance receivables, net
$
(1,640
)
Inventory, net
$
941

Prepaid expenses and other current assets
$
25

Other assets
$
82

Accounts payable
$
270

Accrued expenses
$
803

 
 
Significant Account and Transaction Review and Other:
 
Accounts receivable
$
77

Inventory, net
$
(305
)
Prepaid expenses and other current assets
$
(136
)
Other assets
$
(543
)
Property and equipment, net
$
(1,149
)
Accounts payable
$
25

Accrued expenses
$
8,319

Capital lease obligations and current obligations under long-term debt
$
(21
)
Deferred revenue
$
(27
)
Deferred gain from sale-leaseback transactions
$
(198
)
Deferred gain from sale-leaseback transactions, less current portion
$
(99
)
Common stock
$
(166
)
The tables below present the effect of the financial statement adjustments related to the restatement discussed above of the Company's previously reported financial statements as of and for the three months ended September 30, 2017.
The effect of the restatement on the previously filed condensed consolidated balance sheet as of September 30, 2017 is as follows:
 
As of September 30, 2017
($ in thousands)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Assets
 
 
 
 
 
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
51,870

 
$

 
$
51,870

Accounts receivable
10,288

 
(473
)
 
9,815

Finance receivables, net
3,082

 
(1,641
)
 
1,441

Inventory, net
8,240

 
636

 
8,876

Prepaid expenses and other current assets
1,122

 
(66
)
 
1,056

Total current assets
74,602

 
(1,544
)
 
73,058

 
 
 
 
 
 
Non-current assets:
 
 
 
 
 
Finance receivables due after one year, net
7,742

 

 
7,742

Other assets
750

 
(461
)
 
289

Property and equipment, net
11,850

 
(1,149
)
 
10,701

Deferred income taxes
28,205

 
(28,205
)
 

Intangibles, net
578

 

 
578

Goodwill
11,492

 

 
11,492

Total non-current assets
60,617

 
(29,815
)
 
30,802

 
 
 
 
 
 
Total assets
$
135,219

 
$
(31,359
)
 
$
103,860

 
 
 
 
 
 
Liabilities, convertible preferred stock and shareholders’ equity
 
 
 
 
 
Current liabilities:
 
 
 
 
 
Accounts payable
$
14,211

 
$
295

 
$
14,506

Accrued expenses
3,795

 
8,422

 
12,217

Line of credit, net
7,051

 

 
7,051

Capital lease obligations and current obligations under long-term debt
2,649

 
(21
)
 
2,628

Income taxes payable
10

 
(10
)
 

Deferred revenue

 
439

 
439

Deferred gain from sale-leaseback transactions
197

 
(197
)
 

Total current liabilities
27,913

 
8,928

 
36,841

 
 
 
 
 
 
Long-term liabilities:
 
 
 
 
 
Deferred income taxes

 
109

 
109

Capital lease obligations and long-term debt, less current portion
1,049

 

 
1,049

Accrued expenses, less current portion
62

 

 
62

Deferred gain from sale-leaseback transactions, less current portion
99

 
(99
)
 

Total long-term liabilities
1,210

 
10

 
1,220

 
 
 
 
 
 
Total liabilities
$
29,123

 
$
8,938

 
$
38,061

Commitments and contingencies


 


 


Convertible preferred stock:
 
 
 
 
 
Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,109 at September 30, 2017

 
3,138

 
3,138

Shareholders’ equity:
 
 
 
 
 
Preferred stock, no par value, 1,800,000 shares authorized, no shares issued

 

 

Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,109 at September 30, 2017
3,138

 
(3,138
)
 

Common stock, no par value, 640,000,000 shares authorized, 50,194,731 shares issued and outstanding at September 30, 2017
286,463

 
(167
)
 
286,296

Accumulated deficit
(183,505
)
 
(40,130
)
 
(223,635
)
Total shareholders’ equity
106,096

 
(43,435
)
 
62,661

Total liabilities, convertible preferred stock and shareholders’ equity
$
135,219

 
$
(31,359
)
 
$
103,860

The effect of the restatement on the previously filed condensed consolidated statement of operations for the three months ended September 30, 2017 is as follows:
 
Three months ended September 30, 2017
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Revenue:
 
 
 
 
 
License and transaction fees
$
19,944

 
$
(547
)
 
$
19,397

Equipment sales
5,673

 
189

 
5,862

Total revenue
25,617

 
(358
)
 
25,259

 
 
 
 
 
 
Costs of sales:
 
 
 
 
 
Cost of services
13,326

 
(79
)
 
13,247

Cost of equipment
5,090

 
741

 
5,831

Total costs of sales
18,416

 
662

 
19,078

Gross profit
7,201

 
(1,020
)
 
6,181

 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
Selling, general and administrative
6,746

 
178

 
6,924

Integration and acquisition costs
762

 

 
762

Depreciation and amortization
245

 

 
245

Total operating expenses
7,753

 
178

 
7,931

Operating loss
(552
)
 
(1,198
)
 
(1,750
)
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
Interest income
80

 

 
80

Interest expense
(209
)
 
(264
)
 
(473
)
Total other expense, net
(129
)
 
(264
)
 
(393
)
 
 
 
 
 
 
Loss before income taxes
(681
)
 
(1,462
)
 
(2,143
)
Benefit (provision) for income taxes
468

 
(496
)
 
(28
)
 
 
 
 
 
 
Net loss
(213
)
 
(1,958
)
 
(2,171
)
Preferred dividends
(334
)
 

 
(334
)
Net loss applicable to common shares
$
(547
)
 
$
(1,958
)
 
$
(2,505
)
Net loss per common share
 
 
 
 
 
Basic
$
(0.01
)
 
$
(0.04
)
 
$
(0.05
)
Diluted
$
(0.01
)
 
$
(0.04
)
 
$
(0.05
)
Weighted average number of common shares outstanding
 
 
 
 
 
Basic
47,573,364

 

 
47,573,364

Diluted
47,573,364

 

 
47,573,364



The effect of the restatement on the previously filed condensed consolidated statement of cash flows for the three months ended September 31, 2017 is as follows:
 
Three months ended September 30, 2017
($ in thousands)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
OPERATING ACTIVITIES:
 
 
 
 
 
Net loss
$
(213
)
 
$
(1,958
)
 
$
(2,171
)
Adjustments to reconcile net loss to net cash provided by operating activities:
 
 
 
 
 
Non-cash stock-based compensation
576

 
(167
)
 
409

(Gain) loss on disposal of property and equipment
(18
)
 

 
(18
)
Non-cash interest and amortization of debt discount
15

 
2

 
17

Bad debt expense
118

 
50

 
168

Provision for inventory reserve

 
221

 
221

Depreciation and amortization
1,492

 
(122
)
 
1,370

Excess tax benefits
67

 

 
67

Deferred income taxes
(535
)
 
551

 
16

Recognition of deferred gain from sale-leaseback transactions
(43
)
 
43

 

Changes in operating assets and liabilities:
 
 
 
 
 
Accounts receivable
(3,192
)
 
43

 
(3,149
)
Finance receivables, net
8,771

 
397

 
9,168

Inventory, net
(3,648
)
 
(252
)
 
(3,900
)
Prepaid expenses and other current assets
(217
)
 
114

 
(103
)
Accounts payable and accrued expenses
(2,168
)
 
678

 
(1,490
)
Deferred revenue

 
171

 
171

Income taxes payable

 
(55
)
 
(55
)
Net cash provided by operating activities
1,005

 
(284
)
 
721

 
 
 
 
 
 
INVESTING ACTIVITIES:
 
 
 
 
 
Purchase of property and equipment, including rentals
(992
)
 
272

 
(720
)
Proceeds from sale of property and equipment, including rentals
45

 

 
45

Net cash used in investing activities
(947
)
 
272

 
(675
)
 
 
 
 
 
 
FINANCING ACTIVITIES:
 
 
 
 
 
Issuance of common stock in public offering, net
39,888

 

 
39,888

Repayment of capital lease obligations and long-term debt
(821
)
 
12

 
(809
)
Net cash provided by financing activities
39,067

 
12

 
39,079

 
 
 
 
 
 
Net increase in cash and cash equivalents
39,125

 

 
39,125

Cash and cash equivalents at beginning of year
12,745

 

 
12,745

Cash and cash equivalents at end of period
$
51,870

 
$

 
$
51,870